Aclaris Therapeutics, Inc. (ACRS) — 分析师展望 / 分析师共识目标价为. 基于 16 位分析师评级, 共识为 看涨 — 13 买入, 3 持有.
分析师共识目标价为 $10.00, 上涨空间为 155.1% 相对于当前价格 $3.92.
分析师预估 每股收益(EPS)为 $-0.82 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.71 vs 预期 $-0.82 (不及预期 -108.5%). 2025: 实际 $-0.53 vs 预期 $-0.53 (不及预期 -0.8%). 分析师准确度: 74%.
ACRS 股票 — 12个月价格预测
$10.00
▲ +155.10% 上涨空间
平均目标价
Based on 16 Wall Street analysts offering 12-month price targets for Aclaris Therapeutics, Inc., the price target is $10.00.
平均目标价相对最新价格 $3.92 变动 +155.10%。
ACRS 分析师评级
Buy
基于过去3个月内 16 位分析师对 Aclaris Therapeutics, Inc. 的评级
EPS 预测 — ACRS
74%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$1.71
vs Est –$0.82
▼ 52.0% off
2025
Actual –$0.53
vs Est –$0.53
▼ 0.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — ACRS
75%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.019B
vs Est $0.012B
▲ 38.0% off
2025
Actual $0.008B
vs Est $0.009B
▼ 12.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
